CLOSTRIDIUM HISTOLYTICUM ENZYM

European patent · EP3584317 · In force

Register entry

Publication number
EP3584317
Application number
EP19174182
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jan 10, 2013
Published
Dec 25, 2019
Granted
Nov 24, 2021
Protection ends at the latest
Jan 9, 2033
Next annual fee due
Jan 31, 2027
IPC classes
C12N 9/52 (2006.01)
Priority
US 201261585909 P 12.01.2012
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Feb 1, 2026

    Change

    Published in Swissreg on 01.02.2026

  2. Feb 1, 2025

    Change

    Published in Swissreg on 01.02.2025

  3. Feb 1, 2024

    Change

    Published in Swissreg on 01.02.2024

  4. Feb 1, 2023

    Change

    Published in Swissreg on 01.02.2023

  5. Oct 5, 2022

    Change

    Published in Swissreg on 05.10.2022

  6. Sep 5, 2022

    Address changed

    Owner
    Endo Global Ventures, 22 Victoria Street, Canon's Court, Hamilton HM12, Bermuda → Endo Global Ventures, 31 Victoria Street, Hamilton HM 10, Bermuda

    Published in Swissreg on 05.09.2022

  7. Nov 24, 2021

    Granted

    Published in Swissreg on 24.11.2021

Parties

Holder

Endo Global Ventures

31 Victoria Street, Hamilton HM 10, BM

Inventor

Herber, Wayne

Coopersburg, PA 18036-9306, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.